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Abstract:  The obesity epidemic is also an economic tragedy. This analysis evaluates the 
economic effects and the potential to improve the well-being of both individual and societal 
wealth. Econometric techniques should carefully assess the degree to which obesity affects 
declines in business output, employment, income, and tax revenues at the regional and 
national levels. Microeconomics assesses lost productivity and associated wages and profit. 
Macroeconomics assesses trends associated with employment, inflation, interest rates, money 
supply, and output. To decrease the adverse economic consequences of the obesity epidemic, 
policy makers must emphasize bariatric surgery as a cost-effective option for qualified patients. 
Early intervention, education, and tax rebates for obese individuals who undergo bariatric 
surgery and for medical centers and doctors would likely have positive economic effects on 
the whole economy in a few years.
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Introduction
Obesity afflicts 1 in 3 Americans,1 killing an estimated 100,000 each year.2 Because 
individual health deficits in aggregate adversely impact productivity and median family 
income,3 the obesity epidemic is also an economic tragedy, with adverse microeconomic 
and macroeconomic effects. Evaluating bariatric surgery in this context mandates 
consideration of surgical efficacy, costs, and benefits. This analysis evaluates the eco-
nomical effect of needed policies on obesity with an eye to its clinical implications; 
the results will show bariatric surgery’s potential to improve the well-being of both 
individual health and societal wealth.
Relevant economic notions
Microeconomics studies decision-making of individuals, households, and businesses 
under an assumed constraint of scarce resources. Microeconomic analyses can be 
used to predict outcomes associated with the purchase and consumption of goods and 
services and to assess how price and availability of goods and services affects purchase 
decisions. Microeconomic business analyses relate to production processes, location, 
hiring and compensation practices, pricing strategies, and the choice of products, and 
services to offer. Also assessed are individual productivity, and associated wage and 
profit determinants. In the context of such analyses, inefficiencies that yield negative 
consequences are said to be externalities. Externalities may be reduced when incen-
tives of society and individuals are aligned; such a system of incentives would yield ClinicoEconomics and Outcomes Research 2009:1 80
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wiser decisions with more optimal and efficient economic 
outcomes. An example would be a company that places the 
most nutritious items its cafeteria serves at the most acces-
sible locations to encourage better eating habits, generating a 
healthier, more productive workforce less prone to absentee-
ism. Government support of fitness centers in Canada has 
been shown to be effective in reducing lost work days and 
in net economic benefits.4
Macroeconomics examines the movements and trends 
in economy-wide aggregate variables such as employment, 
inflation, interest rates, money supply and output. Perfectly 
competitive markets work imply that the value of the mar-
ginal product of the last worker hired is the market wage for 
the laborer, a relationship described by VMP = p × MP = W, 
where VMP is the value of the marginal product, p is the price, 
MP is the marginal product, and W is the wage of the laborer. 
Hence, VMP is the demand for labor. Obesity, by lowering 
MP, decreases the demand for labor. On a practical basis, 
this occurs when employers find expenses accrued by using 
an obese work force surpass the value of what the laborers 
produce; the response is to outsource work to thinner laborers 
(or laborers with less generous health benefits) or to reduce 
the use of labor entirely by automation. Because VMP = W, 
real wages decline when VMP decreases. Decreased W 
can express itself as a decrease in the size of the paycheck 
and/or an increase in the cost of living. Current data suggest 
that inflation, rather than decreased paycheck amounts, will 
result from obesity.
The tradeoff between dollars used for health care and 
dollars used to increase general economic productivity can 
be evaluated within the context of a production possibilities 
frontier (PPF). Figure 1 displays two PPF curves on an 
imaginary island that produces only laptop computers, 
displayed on the Y axis and laparoscopic adjustable bands, 
displayed on the X axis. The numbers of laptop computers 
and laparoscopic adjustable bands produced at four different 
places on the island are measured, for the upper curve in 
1980 and the bottom curve in 1995, after additional supplies 
of rubber were discovered, making laparoscopic band 
manufacture less expensive. The curves are said to be the 
ideal, points outside them being impossible and inside them 
being inefficient. The upper curve is within the bounds of the 
lower curve precisely because the relative lack of rubber made 
the production of laparoscopic bands inefficient. The bottom 
curve would also have been moved to the right had a more 
efficient means of manufacturing laparoscopic bands been 
created. A curve can also shift to the left, as might occur when 
a supplier ceases to exist. The notion can be applied to the 
economy in general. As obesity increases the cost of providing 
health care to a society’s citizens, an inefficiency develops, 
such that a curve with adequate health care per person on 
the X axis and adequate housing per person on the Y axis is 
shifted to the left. Obesity, by diverting moneys from general 
technologic innovation, shifts the curve for the economy in 
general to the left. In the longer term, a lower capital stock 
results in a lower standard of living in the future.
Who really pays for the prevalence of obesity in the 
economy? Answering this question requires an understanding 
of the gross domestic product. The famed GDP (Y) comprises 
four components, consumption (C), investment (I), govern-
ment (G) and net exports (X). If each component is viewed 
as a proportion of Y, an equation can be created, 1 = Y = C + 
G + I + X. Viewed proportionately, rises in G required to cover 
additional government provided health benefits requires I, X, 
or C to fall alone or in combination. Over half the direct 
medical cost of obesity is born by publicly funded programs, 
such as Medicare and Medicaid.1 Analogous to the situation 
with respect to the general economy, as the proportion of 
government spending that accrues from obesity increases, 
the fraction available for other government services, such 
as education and building roads, decreases. In general, the 
result is less likely a trade off within the arena of government 
spending than an increment in G. Given decreased VMP 
from increased insurance premiums, I is the most likely to 
decrease, decreasing purchases of new equipment, machinery, 
and factories. A dollar spent on I will generally yield more 
future output than a dollar spent on G. Moreover, decreased 
VMP means decreased W, which decreases consumer 
spending C. Given an increased cost of employment, any 
demand for a product is more likely to be satisfied by the labor 
in other thinner nations, decreasing net exports X. The end 
result is an increase in G and a decrease in I, X, and C. Thus, 
C falls along with I. The resultant increase in government debt 
has two negative effects. First, taxes must rise, decreasing the 
amount of money in the economy itself. Second, borrowing 
exerts an upward pressure on interest rates, given that govern-
ment competes with the private sector for funding of loans. 
The analysis, generalized to the federal level, is analogous 
to that used at the state level. Ultimately, the conclusion that 
all pay obesity’s costs is inescapable.
Costs of obesity and benefits  
of bariatric surgery
Real dollar figures make the above more meaningful. 
In 1998, medical spending for obesity accounted for 9.1% 
of  US health expenditures,5 with an estimated annual ClinicoEconomics and Outcomes Research 2009:1 81
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$74 billion in direct costs in 2008 US dollars.6 By 2008, 
the estimated direct medical cost had risen to $143 billion.4 
Obesity increases the negative effects of diabetes, dislip-
idemia, and hypertension on medical spending by 33%, 
60%, and 58% and the number of lost workdays by 180%, 
72%, and 221%, respectively.7 An evaluation of workman’s 
compensation data revealed that the number of lost work-
days was almost 13 times higher, medical claims costs were 
7 times higher, and indemnity claims costs were 11 times 
higher among the heaviest employees compared with those 
of recommended weight.8 What this means is that obesity 
costs a firm with 1,000 employees about $285,000 per year.4 
The results extend to the economy as a whole: New Mexico 
was estimated to have experienced a negative economic 
impact accounting for 2.5% of its gross state product, with 
an associated 7,300 lost jobs.9
Bariatric surgery has been shown to be an effective 
treatment for morbid obesity and its co-morbidities. Two 
years after the procedure, bariatric surgery patients are 
0.38 times as likely to be hypertensive, 0.02 times as likely to 
1200
1000
1200 1000
Laparoscopic adjustable bands
L
a
p
t
o
p
 
c
o
m
p
u
t
e
r
s
800
800
600
600
400
400
Inefficient production
381 bands
888 laptops
Impossible
756 bands
302 laptops
200
200
0
0
1200
1000
1200 1000
Laparoscopic adjustable bands
L
a
p
t
o
p
 
c
o
m
p
u
t
e
r
s
800
800
600
600
400
400
Inefficient production
476 bands
879 laptops
Impossible
945 bands
327 laptops
200
200
0
0
Figure 1 Production possibility frontier curves for an imaginary island that produced laptop computers and laparoscopic adjustable bands before (top half) and after (bottom 
half) the discovery of new rubber sources that made the bands less expensive to produce.ClinicoEconomics and Outcomes Research 2009:1 82
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have diabetes, and 0.10 as likely to have hypertriglyceridemia 
as are non-surgically treated controls.10 In terms of years 
of added life, gastric bypass yields an estimated 2.6 added 
years for a 40 year old obese woman.11 The effect on diabetes 
is often independent of its effect on weight control; when 
matched with patients of equivalent weights, one study 
found that those who undergo gastric bypass show lower 
levels of serum leptin, fasting insulin, and blood glucose.12 
Indeed, for patients who undergo gastric bypass and bilio-
pancreatic diversion, the data show that 80% to 100% of 
severely diabetic patients achieve durable euglycemia, usually 
within days of the procedure.13 The least invasive procedure, 
laparoscopic adjustable gastric banding, yields control of 
both hypertension and diabetes in 85.4% of patients.14 The 
more restrictive procedures effect their changes in part 
hormonally; laparoscopic sleeve gastrectomy alters ghrelin 
levels, an effect not seen with gastric banding.15 Studies of 
non-obese diabetic rats suggest that the small intestine bears 
much of the responsibility for euglycemia.16 That restriction 
related changes in hormones may play a role in weight loss 
itself is shown a study that showed that patients who under-
went sleeve gastrectomy had a better weight loss and a lower 
craving for sweets than did those who underwent gastric 
banding.17 Non-operative techniques simply lack efficacy 
when compared to bariatric surgery.
Government commitments
Government policy changes that might favor bariatric surgery 
should be considered after careful study. Analyses must be 
conducted to determine the risk factors associated with treat-
ment success and failure, shedding light on the “market forces 
from the demand side to better determine who should receive 
the surgery. Continuous quality improvement is mandatory to 
convince payers of the value of the surgery, with a focus first 
on life-cycle costs of bariatric procedures, centers/facilities, 
technological advances, and quality assurance processes. 
This would be followed by analyses of continuous quality 
improvement programs, with attention directed to: delivery 
and quality, assessment, cost containment, financial improve-
ment, cost reduction strategies, cost savings, service design 
processes, and forcasting. Attention would then focus on 
clinical and economic outcomes, with a generalized national 
scope. Clinical metrics would include 30-day mortality rates 
for those undergoing the surgery and proportion of patients 
within the five year period after surgery that require second 
procedures. Patients should be followed over their lifetimes, 
so as to create the most accurate cost-benefit and cost effec-
tiveness analyses.11 Econometric techniques should carefully 
assess the degree to which obesity affects declines in business 
output, employment, income, and tax revenues at the regional 
and national levels. Because clinical outcomes are inherently 
linked to a variety of economic benefits and costs, such as 
work life expectancy, absenteeism, societal welfare, cost-
benefit models must explore a wide array of parameters, with 
reassessment provided with every major technologic advance. 
Notwithstanding these research objectives, the evidence 
is strong enough to merit consideration of tax incentives 
for bariatric surgical centers and reductions in malpractice 
burdens for those who perform the procedures, as well as 
increased moneys for the training of bariatric surgeons.
The major disease syndrome accorded to obesity, the 
metabolic syndrome, comprises high blood pressure, high 
cholesterol, high triglycerides, diabetes or glucose intolerance, 
respiratory difficulties, cardiovascular difficulties, and an 
increased risk of deep venous thrombosis, as well as multiple 
other problems. Weight loss ameliorates and often completely 
resolves most of diseases related to metabolic syndrome. 
Bariatric surgery has been shown to dramatically improve 
these medical conditions, to the extent that formerly obese 
persons can live more productive and complete lives; no other 
form of weight control has comparable efficacy. To decrease 
the adverse economic consequences of the obesity epidemic, 
policy makers must emphasize bariatric surgery as a cost-
effective option for qualified patients. A general policy 
program should first be directed to individual decisions with 
respect to lifestyle changes. Reductions in obesity, through 
incentives with respect to exercise programs and nutrition, such 
as a tax on sugar, would reduce negative externalities to some 
degree. Tax rebates for obese individuals who undergo bariatric 
surgery would likely be more efficient because the money is 
directed to those most likely to accrue increased health costs. 
Education is vital, both with respect to increasing knowledge 
of the costs of obesity and to explaining when bariatric surgery 
is an appropriate option. Medical centers and doctors could be 
incentivized through tax rebates to perform bariatric surgery. 
The costs of such a plan would likely be offset by the positive 
economic impacts of surgery within a few years.18
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